Apigenin inhibited HIF-1α in HepG2 cells, and decreased the expression of glycolytic related proteins (HK2, LDHA, PDHK1), thereby inhibiting the anti-cancer effect of glycolysis (张睿 et al., 2020). The gene discussed is LDHA; the disease is cancer.